Tweenvest Stocks

Bioray Biotech Co., Ltd (TPEX: 7561)

Health Care · Biotechnology · TW

NT$18.00

-3.23% today · -25.9% 1Y

Bioray Biotech Co., Ltd (TPEX: 7561) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.41M and employs 79 people.

Over the last twelve months the share price has lost 25.9%, trading between 15.50 and 26.10.

Tweenvest scores Bioray Biotech Co., Ltd across four factors: quality 75/100, value 57/100, growth 19/100, dividend 56/100. Its strongest factor is quality.

7561 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$16.41M
Revenue (TTM)
$6.51M
P/E
27.76
EPS
0.65
Dividend yield
5.28%
Beta (5Y)
0.16
52-week high
NT$26.10
52-week low
NT$15.50
Avg volume (3M)
—
Shares outstanding
29.59M
Employees
79
Next earnings
—

About Bioray Biotech Co., Ltd

Bioray Biotech Co., Ltd is dedicated to the innovation, manufacturing, and distribution of biological and health supplement products. The company's biological offerings span specialized functional probiotics, therapeutic fungi, and immune cell preparations. Additionally, Bioray Biotech extends its expertise to the field of cellular testing and preservation services. Founded in 1994, this Taiwanese firm is based in Pingtung.

ISIN
TW0007561B13
Founded
2005
Listed since
Jul 27, 2020
Exchange
Taipei Exchange
Currency
TWD
CompanyMarket capPriceDay
NeuroScientific Biopharmaceuticals LimitedASX: NSB$16.54MAU$0.06+5.17%
Daesung Microbiological Labs. Co., Ltd.KOSDAQ: A036480$16.50M₩5,790.00-3.50%
Vectorite Biomedical Inc.TPEX: 4170$16.46MNT$12.20-2.79%
Shaperon Inc.KOSDAQ: A378800$16.44M₩2,370.00-11.57%
Biotechnology Assets, S.A.BME: BST$16.39M€0.20+6.85%
aTyr Pharma, Inc.NasdaqCM: ATYR$16.19M$0.17-2.88%
Psyence Biomedical Ltd.NasdaqCM: PBM$16.10M$4.22-15.09%
TScan Therapeutics, Inc.NasdaqGM: TCRX$15.66M$0.23-2.94%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.